Mkts

Viridian Therapeutics, Inc.

NASDAQ: VRDN
$30.87+0.39 (+1.28%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
29.8130.96
52-week range
13.1834.29
Today
Open30.24
Previous close30.87
Volume—
Valuation
Market cap3.35B
P/E ratio—
EPS (TTM)-3.90
Income & risk
Dividend / yield—
Beta1.06
Avg volume2.01M
Discussion

VRDN News

Stories mentioning VRDN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development
Sales General & Admin38,67917,103
Total Operating Expenses116,310122,881110,583106,84293,93887,54383,56672,259
Operating Income (Loss)(116,169)(122,749)(40,013)(106,767)(93,866)(87,471)(83,480)(72,187)
Interest Income7,8725,5217,5407,515
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(104,901)(120,355)(34,599)(100,735)(86,912)(79,725)(76,689)(64,993)
Earnings Per Share (Basic)(1.15)(1.02)
Earnings Per Share (Diluted)(1.15)(1.02)
Weighted Average Shares Outstanding (Basic)66,42063,855
Weighted Average Shares Outstanding (Diluted)81,34466,42063,855

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VRDN

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is a stock listed on the Nasdaq Stock Market under the ticker symbol VRDN. It last traded at $30.87 (Nov 13, 2026, 4:00 PM ET), up 1.3% on the day. That gives Viridian Therapeutics a market capitalisation of $3.4B.

Over the past 52 weeks VRDN has traded between $13.18 and $34.29.

For the quarter ended Mar 31, 2026 it reported a net loss of $104.9M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$104.9M
Dec 31, 2025—-$120.4M
Sep 30, 2025—-$34.6M
Jun 30, 2025—-$100.7M

From Viridian Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…